TABLE III.
Tumour markers in pleural fluida in cases of malignant and benign pleural effusions
| Marker | Case group | p Value | |
|---|---|---|---|
|
| |||
| Malignant (n=114) | Benign (n=42) | ||
| Carcinoembryonic antigen (ng/mL) | 14.0 (2.6–139.4) | 1.3 (1.0–2.2) | ≤0.001 |
| Cancer antigen 15-3 (U/mL) | 41.0 (14.0–190.0) | 13.5 (10.2–21.6) | ≤0.001 |
| Carbohydrate antigen 19-9 (U/mL) | 7.9 (2.1–38.0) | 5.9 (1.8–12.0) | 0.152 |
| Cancer antigen 72-4 (U/mL) | 7.1 (3.9–58.5) | 6.8 (6.1–7.2) | 0.059 |
| Cancer antigen 125 (U/mL) | 796.0 (258.0–1831.0) | 86.5 (22.3–305.2) | ≤0.001 |
| CYFRA 21-1 (U/mL) | 57.8 (18.7–271.3) | 19.5 (10.3–47.4) | ≤0.001 |
a
Values expressed as medians, with interquartile range in parentheses.